Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pregnant women's presumed inclusion in clinical research called for in HHS proposal.

This article was originally published in The Tan Sheet

Executive Summary

PREGNANT WOMEN's PRESUMED INCLUSION IN CLINICAL RESEARCH is called for by HHS in an advance notice of proposed rulemaking published in the May 20 Federal Register. The proposed rule "institutes a policy of presumed opportunity for inclusion of pregnant women in research in place of one of presumed exclusion," HHS states. In other words, pregnant women should be allowed to be participants in clinical trials unless there are compelling reasons to prevent their inclusion. HHS invites comments on the proposed rule, which modifies 45 CFR 46 Subpart B, until Aug. 18.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS088475

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel